This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stern, L. L. Articles by Choi, S.-W. Search for Related Content PubMed PubMed Citation Articles by Stern, L. L. Articles by Choi, S.-W.

Genomic DNA Hypomethylation, a Characteristic of Most Cancers, Is Present in Peripheral Leukocytes of Individuals Who Are Homozygous for the C677T Polymorphism in the Methylenetetrahydrofolate Reductase Gene¹

Vitamin Metabolism Laboratory, Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
DNA methylation is an epigenetic feature of DNA that influences cellular development and function, and aberrations of DNA methylation are a candidate mechanism for the development of cancer. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the synthesis of 5-methyltetrahydrofolate, the methyl donor for methionine synthesis and the precursor of S-adenosylmethionine. S-adenosylmethionine is the universal methyl donor for methylation reactions, including that of DNA methylation. In the present study, we investigated whether a common C677T mutation in the MTHFR gene, which results in reduced enzyme activity in vitro, affects genomic DNA methylation. We selected 9 subjects homozygous for the wild-type MTHFR and 10 subjects homozygous for the mutation (T/T). Genomic DNA methylation was determined by an established enzymatic assay that measures the capacity of DNA to accept methyl groups in vitro, which is inversely related to endogenous methylation. DNA from subjects with the T/T MTHFR genotype had a significantly higher methyl group acceptance capacity (12,615 ± 1836 dpm/2 µg of DNA) compared with wild-type MTHFR (7843 ± 1043 dpm/2 µg of DNA; P < 0.05), indicating DNA hypomethylation in the T/T genotype. Furthermore, DNA methylation was directly and significantly related to RBC folate concentrations in persons with the T/T genotype, but not in those with wild-type MTHFR. These data are consistent with prior observations, which suggest that the T/T genotype is associated with impaired MTHFR activity in vivo and that the cellular impact of this impairment is determined, in part, by folate status. The relationship of genomic DNA hypomethylation in persons with the T/T MTHFR genotype to the development of cancer remains to be defined.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
MTHFR³ [5-methyltetrahydrofolate: (acceptor) oxidoreductase, EC 1.7.99.5] catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5-methylTHF, the methyl donor for the synthesis of methionine from homocysteine. Methionine is the immediate precursor of SAM, the universal methyl donor for a multitude of biological methylation reactions (1) . Included among these essential methylation reactions is DNA methylation, which occurs almost exclusively at CpG dinucleotide repeats in the human genome. This epigenetic modification of DNA has been shown to serve several functional roles, including the suppression of gene expression (2, 3) and the enhancement of genomic stability (4, 5) . DNA methylation, therefore, has important effects on cellular development and function. Consistent with this are many observations, which have demonstrated that aberrations in normal patterns of DNA are associated with the development of cancer (6) .

Several studies have shown that DNA methylation can be modified by limiting the supply of methyl groups in the diet (7–9) , and it is of considerable import that this dietary modification alone is sufficient to produce neoplasms in the liver (10, 11) . In a rodent model, a methyl-deficient diet (i.e., combined methionine, choline, and folate deficiency) diminished tissue concentrations of SAM and produced genomic DNA hypomethylation in the liver (7) . Gene-specific DNA hypomethylation has also been observed under the condition of folate deficiency alone (8) . Furthermore, extended depletion of folate among human subjects in a metabolic ward has been observed to produce genomic DNA hypomethylation (9) .

Of increasing interest is a common cytosine-to-thymidine transition in the MTHFR gene at nucleotide 677 (C677T), which is prevalent in its homozygous form in 10% of the population (12) . This mutation results in an alanine-to-valine substitution in the MTHFR protein and, as shown in in vitro studies using cell extracts, renders the enzyme less active and more susceptible to heat inactivation compared with the wild-type enzyme (12, 13) .

Data from recent studies suggest that the in vivo activity of the thermolabile form of MTHFR is also impaired. As outlined in a review by Rozen (14) , persons homozygous for the mutation (T/T) generally have mild elevations in plasma homocysteine concentrations compared with those with wild-type MTHFR, particularly when folate status is inadequate. This observation demonstrates how folate status and the MTHFR genotype interact to determine the phenotype and implies that persons with the T/T genotype synthesize insufficient quantities of 5-methylTHF for the remethylation of homocysteine to form methionine. Indeed, we have recently shown that the T/T MTHFR genotype results in a lower proportion of methylated forms of folate in RBCs compared with RBC folates from persons with the wild-type MTHFR (15) .

The goal of the present study was to assess the impact of the C677T mutation on an important cellular process that uses the 5-methylTHF synthesized in the reaction catalyzed by MTHFR. We have demonstrated that genomic DNA methylation is diminished in persons homozygous for the C677T mutation in the MTHFR gene. Furthermore, we investigated whether genomic DNA methylation in persons with the T/T MTHFR genotype was related to folate status. This is the first report to date, which demonstrates that the T/T MTHFR genotype can alter an epigenetic feature of DNA that has been closely linked to carcinogenesis.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Approval for this protocol was obtained from the Tufts-Human Nutrition Research Center Institutional Review Board. Healthy adult volunteers ranging in age from 25 to 75 years were selected according to MTHFR genotype. Nine subjects were wild-type (C/C) and 10 subjects were homozygous for the C677T mutation (T/T). Peripheral blood samples were collected after an overnight fast and stored at -70°C until analyses were performed. We determined fasting plasma and RBC folate concentrations in each participant by a conventional microbial assay using Lactobacillus casei (16) . Fasting total homocysteine concentrations were measured by high-performance liquid chromatography with fluorescence detection (17) .

DNA was isolated from peripheral leukocytes using a standard technique (18) . Cells were lysed using a buffer containing proteinase K, and DNA was extracted with phenol, chloroform, and isoamyl alcohol. All DNA samples were of high molecular weight (>20 kb), as assessed by gel electrophoresis, and had an A₂₆₀:A₂₈₀ absorbance ratio >1.8. DNA was frozen at -70°C until used for assay.

MTHFR genotype was determined by PCR-RFLP analysis based on the method described by Frosst et al. (12) . Briefly, a 198-bp fragment was amplified by PCR using the primers 5'-TGAAGGAGAAGGTGTCTGCGGGA-3' and 5'-AGGACGGTGCGGTGAGAGTG-3'. The presence of the mutant T allele creates a HinfI restriction site resulting in two fragments (175 and 23 bp), the larger of which can be visualized after gel electrophoresis and ethidium bromide staining.

To determine genomic DNA methylation, we used a method that has been detailed previously (19) with minor modifications. This method uses [³ H]methyl-SAM and DNA methyltransferase for the in vitro transfer of radiolabeled methyl groups to unmethylated sites on DNA. Therefore, DNA with lower methylation in vivo will have a greater capacity to accept the radiolabeled methyl groups in this assay. The ability of this method to discriminate between different degrees of in vivo DNA methylation has been previously validated (19, 20) .

DNA samples (2 µg) were incubated for 2 h at 37°C with 185 kBq [³ H]methyl-SAM (20.4 GBq/liter; New England Nuclear, Boston, MA) and 4 units of Sss1 methylase (New England Biolabs, Beverly, MA) in 5 µl of 10x methylation buffer II (New England Biolabs) plus TE buffer [10 mM Tris-HCl, 10 mM EDTA (pH 8.0)] added to a final volume of 50 µl/incubation. The methylation reaction was stopped by heating the samples at 65°C for 20 min. The incubation mixtures were washed onto discs of Whatman DE-81 paper (Fisher Scientific, Springfield, NJ) by using a vacuum filtration apparatus, and then soaked in 50 ml of 0.35 M dibasic sodium phosphate for 30 min. The discs were then dried at 95°C for 30 min, and the resulting radioactivity of the DNA retained in the discs was measured by scintillation counting using a nonaqueous scintillant. All analyses were performed in triplicate.

Mean differences between the wild-type and T/T MTHFR genotypes were determined by the Student’s t test for independent samples. Regression analysis was applied to determine the effect of folate status on genomic DNA methylation. All results were considered significant if the two-tailed observed significance level (P) was <0.05. The DNA methylation data were also log-transformed to attain a more normal distribution of the data; however, this transformation did not affect the significance level. Therefore, the results are presented using untransformed data. Values are means ± SD.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Table 1 shows the general characteristics of the two study groups according to MTHFR genotype. The two groups did not differ by age, gender representation, or measures of folate status (i.e., plasma and RBC folate and plasma homocysteine concentrations).

View larger version (13K): [in this window] [in a new window]   Fig. 1. Genomic DNA methylation. In vitro [3H]methyl acceptance capacity was measured in DNA from persons homozygous for the C677T mutation in the MTHFR gene (T/T) and compared with that of persons with wild-type MTHFR (C/C). The degree of endogenous genomic DNA methylation is inversely related to the incorporation of exogenous tritiated methyl groups. *, a significant difference between the two genotypes (P = 0.04). The value for each individual is shown (). Bars, mean values for each genotype.

View larger version (17K): [in this window] [in a new window]   Fig. 2. Genomic DNA methylation and folate status. Linear relationship of [3H]methyl acceptance capacity in DNA to RBC folate concentrations in persons with wild-type MTHFR (A) and in subjects homozygous for the C677T mutation in the MTHFR gene (T/T genotype; B). No correlation was observed in persons with wild-type MTHFR; however, there was a significant and inverse association in the T/T genotype subjects. One data point is missing because of damage in storage.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

An interaction between folate status and the C677T mutation has recently been demonstrated, and this has enhanced the interpretation of how this mutation may affect the biochemical measures and clinical outcomes of persons with the T/T genotype. For example, Jacques et al. (30) showed that persons with the T/T genotype and inadequate folate status have significant elevations in plasma homocysteine compared with persons with either the wild-type or heterozygous genotypes. Under the condition of adequate folate status, however, homocysteine levels are low and do not differ between genotypes. This relationship has subsequently been shown by several others (31, 32) .

Another important example of this gene-nutrient interaction has been shown in relation to the cancer protective effect of the T/T genotype (26–28) . These studies reported a 50% reduction in colorectal cancer risk in both men and women with the T/T genotype compared with persons with wild-type MTHFR. This protection was no longer evident, however, when blood folate levels or folate intakes were low. In fact, a recent study by Ulrich et al. (33) suggests that the T/T genotype becomes a risk factor for colorectal adenoma under the condition of low folate intake.

In an attempt to further understand the relationship between folate status and this mutation, Guenther et al. (34) recently studied the properties of a thermolabile MTHFR expressed in Escherichia coli, which exists in the dimer (inactive) and tetramer (active) forms. These studies showed that the mutation results in a weakening of the association between flavin-adenine dinucleotide and the enzyme, rendering the enzyme more susceptible to disassociation to the inactive dimer form. Folate substrates appear to protect against this inactivation by causing the flavin-adenine dinucleotide molecule to be buried in its binding site and less able to be released from the enzyme. The human MTHFR protein differs from the E. coli enzyme by the fact that it exists only as a dimer and also has an additional peptide region that binds SAM, an allosteric inhibitor of the enzyme. Nevertheless, the studies by Guenther et al. (34) did show that folate substrate protects the E. coli and human mutant (and normal) enzymes from thermal inactivation.

These in vitro studies provide a reasonable interpretation for the epidemiological association between folate status and the C677T mutation. However, there still remains to be determined how this interaction is specifically manifested in human cells and tissues. In the present study, we assessed a possible biological effect of this mutation in DNA from peripheral WBCs, a tissue with active folate metabolism. We have shown that persons homozygous for the common C677T mutation in the MTHFR gene have lower genomic DNA methylation compared with persons with wild-type MTHFR. Moreover, we observed that DNA methylation in persons with the T/T genotype was directly correlated with RBC folate, a feature that was not seen in the DNA from subjects with wild-type MTHFR.

The most reasonable interpretation of these observations is that the activity of the T/T MTHFR variant is impaired in vivo and that this impairment is dependent on limited substrate availability. Hence, the lower activity of the T/T MTHFR variant limits the availability of methyl groups from 5-methylTHF for the synthesis of SAM, thereby reducing the cellular capacity to methylate many biological molecules, including DNA.

A previous study in these same study participants showed that the distribution of folate forms in RBCs was altered as a result of the T/T MTHFR genotype (15) . Specifically, RBCs from persons with wild-type MTHFR exclusively contained methylTHF polyglutamates, whereas RBCs from persons with the T/T genotype contained formylTHF polyglutamates in addition to methylTHF polyglutamates. These data suggest there is an impairment on the part of the T/T MTHFR variant to convert precursor forms of reduced folates to the methyl derivative. Our present study demonstrates a functional consequence of this reduced availability of methylated folates in the blood cells of persons with the T/T genotype.

Our observation of a folate-methylation relationship is entirely consistent with epidemiological evidence suggesting that the activity of the T/T genotype MTHFR is further impaired when folate status is inadequate. Notably, we see a graded effect of RBC folate status on genomic DNA methylation in T/T genotype individuals without frank folate deficiency. This demonstration that hypomethylation is related to modest reductions in RBC folate, a measurement indicative of tissue folate stores, implies that genomic DNA methylation in peripheral leukocytes may serve as a sensitive and functional biomarker of folate status in persons with the T/T MTHFR genotype. The relationships we have demonstrated here are based on a limited number of subjects and therefore need to be confirmed in a larger population. However, despite the limited size of the study population, the relationships are quite robust and are therefore quite provocative.

The potential clinical ramifications resulting from the lower genomic DNA methylation observed in persons homozygous for the T/T MTHFR are less clear. Aberrant patterns of DNA methylation are commonly observed in carcinogenesis; diminished genomic and site-specific DNA methylation is an exceedingly common observation (35, 36) . Nevertheless, the relevance of our findings to the process of cancer development has yet to be determined. In the case of the C677T mutation, the protection against the development of colorectal cancer is thought to be attributable to an enhanced availability of nonmethylated folate substrates for the de novo synthesis of purines and thymidylates for DNA synthesis and repair (27) . Reports that the T/T MTHFR genotype is no longer protective when folate status is low are consistent with the possibility that under this condition, an exaggerated degree of DNA hypomethylation negates the protective effect produced by the increased availability of nucleotides.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Supported in part by NIH Training Grant AG00209-07 (to L. L. S.), NIH Grant RO1 CA59005-0S81 (to J. B. M.), and the Cancer Research Foundation of America (to S. W. C.). This work is also based on work supported by the United States Department of Agriculture under agreement 58-1950-9-001.

² To whom requests for reprints should be addressed, at Vitamin Metabolism Laboratory, Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111. Phone: (617) 556-3356; Fax (617) 556-3166; E-mail: schoi{at}hnrc.tufts.edu

³ The abbreviations used are: MTHFR, methylenetetrahydrofolate reductase; THF, tetrahydrofolate; SAM, S-adenosylmethionine; T/T, homozygous for the C677T transition in the MTHFR gene.

Received 12/28/99; revised 5/10/00; accepted 5/21/00.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Selhub J., Miller J. W. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr., 55: 131-138, 1991.[Abstract/Free Full Text]
2. Bird A. P. CpG-rich islands and function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.[Medline]
3. Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature (Lond.), 366: 362-365, 1993.[Medline]
4. Lengauer C., Kinzler K. W., Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl. Acad. Sci. USA, 94: 2545-2550, 1997.[Abstract/Free Full Text]
5. Kundu T. K., Rao M. R. S. CpG islands in chromatin organization and gene expression. J. Biochem. (Tokyo), 125: 217-222, 1999.[Abstract/Free Full Text]
6. Schmutte C., Jones P. A. Involvement of DNA methylation in human carcinogenesis. Biol. Chem., 379: 377-388, 1998.
7. Pogribny I. P., Basnakian A. G., Miller B. J., Lopatina N. G., Poirier L. A., James S. J. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res., 55: 1894-1901, 1995.[Abstract/Free Full Text]
8. Kim Y. I., Pogribny I. P., Basnakian A. G., Miller J. W., Selhub J., James S. J., Mason J. B. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am. J. Clin. Nutr., 65: 46-52, 1997.[Abstract/Free Full Text]
9. Jacob R. A., Gretz D. M., Taylor P. C., James S. J., Pogribny I. P., Miller B. J., Henning S. M., Swendseid M. E. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr., 128: 1204-1212, 1998.[Abstract/Free Full Text]
10. Mikol Y. B., Hoover K. L., Creasia D., Poirier L. A. Hepatocarcinogenesis in rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis (Lond.), 4: 1691-1929, 1983.
11. Ghoshal, A. K., and Farber, E. The induction of liver cancer by a dietary deficiency of choline and methionine without added carcinogens. Cancer Res., 5: 1367–1370.
12. Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, >G. J. H., denHeijer, M., Kluijtmans, L. A. J., van den Heuvel, L. P., and Rozen, R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 10: 111–113, 1995.
13. Kang S. S., Zhou J., Wong P. W. K., Kowalisyn J., Strokaosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet., 43: 414-421, 1988.[Medline]
14. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb. Haemost., 78: 523-526, 1997.[Medline]
15. Bagley P. J., Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc. Natl. Acad. Sci. USA, 95: 13217-13220, 1998.[Abstract/Free Full Text]
16. Tamura T. Microbiological assay of folate Picciano M. F. Stokstad E. L. R. Gregory J. F. eds. . Folic Acid Metabolism in Health and Disease, pp., : 121-137, Wiley-Liss New York 1992.
17. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J. Chromatogr., 422: 43-52, 1987.[Medline]
18. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory ManualEd Cold Spring Harbor Laboratory Press 2. Cold Spring Harbor, New York 1989.
19. Kim Y. I., Christman J. K., Fleet J. C., Cravo M. L., Salomon R. N., Smith D., Ordovas J., Selhub J., Mason J. B. Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am. J. Clin. Nutr., 61: 1083-1090, 1995.[Abstract/Free Full Text]
20. Kim Y. I., Giuliano A., Hatch K. D., Schneider A., Nour M. A., Dallal G. E., Selhub J., Mason J. B. Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer (Phila.), 74: 893-899, 1994.[Medline]
21. Kang, S. S., Passen, E. L, Ruggie, N., Wong, P. W. K., and Sora, H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation, 88: 1463–1469, 1993.
22. Kluijtmans L. A. J., van den Heuvel L. P. W. J., Boers G. H., Frosst P., Stevens E. M. B., van Oost B. A., den Heijer M., Trijbels F. J. M., Rozen R., Blom H. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet., 58: 35-41, 1996.[Medline]
23. Folsom A. R., Nieto F. J., McGovern P. G., Tsai M. Y., Malinow M. R., Eckfeldt J. H., Hess D. L., Davis C. E. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. Circulation, 98: 204-210, 1998.[Abstract/Free Full Text]
24. Girelli D., Friso S., Trabetti E., Olivieri O., Russo C., Pessotto R., Faccini G., Pignatti P. F., Mazzucco A., Corrocher R. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from Northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood, 91: 4158-4163, 1998.[Abstract/Free Full Text]
25. Brattstrom L., Wilcken D. E. L., Ohrvik J., Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease. Circulation, 98: 2520-2526, 1998.[Abstract/Free Full Text]
26. Chen J., Giovannucci E., Kelsey K., Rimm E. B., Stampfer M. J., Colditz G. A., Spiegelman D., Willett W. C., Hunter D. J. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res., 56: 4862-4864, 1996.[Abstract/Free Full Text]
27. Ma J., Stampfer M. J., Giovannucci E., Arigas C., Hunter D. J., Fuchs C., Willett W. C., Selhub J., Hennekens C. H., Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res., 57: 1098-1102, 1997.[Abstract/Free Full Text]
28. Slattery M. L., Potter J. D., Samowitz W., Schaffer D., Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol. Biomark. Prev., 8: 513-518, 1999.[Abstract/Free Full Text]
29. Skibola C. F., Smith M. T., Kane E., Roman E., Rollinson S., Cartwright R. A., Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl. Acad. Sci. USA, 96: 12810-12815, 1999.[Abstract/Free Full Text]
30. Jacques P. F., Bostom A. G., Williams R. R., Ellison R. C., Eckfeldt J. H., Rosenberg I. H., Selhub J., Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation, 93: 7-9, 1996.[Abstract/Free Full Text]
31. Verhoeff B. J., Trip M. D., Prins M. H., Kastelein J. J. P., Reitsma P. H. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. Atherosclerosis, 141: 161-166, 1998.[Medline]
32. Tokgozoglu S. L., Alikasifoglu M., Unsal I., Atalar E., Aytemir K., Ozer N., Ovunc K., Usal O., Kes S., Tuncbilek E. Methylenetetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate. Heart, 81: 518-522, 1999.[Abstract/Free Full Text]
33. Ulrich C. M., Kampman E., Bigler J., Schwartz S. M., Chen C., Bostick R., Fosdick L., Beresford S. A. A., Yasui Y., Potter J. D. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?. Cancer Epidemiol. Biomark. Prev., 8: 659-668, 1999.[Abstract/Free Full Text]
34. Guenther B. D., Sheppard C. A., Tran P., Rozen R., Matthews R. G., Ludwig M. L. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat. Struct. Biol., 6: 359-365, 1999.[Medline]
35. Gama-Sosa M. A., Slagel V. B., Trewyn R. W., Oxenhandler R., Kuo K. C., Gehrke C. W., Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res., 11: 6883-6894, 1983.[Abstract/Free Full Text]
36. Jones P. A., Buckley J. D. The role of DNA methylation in cancer. Adv. Cancer Res., 54: 1-23, 1990.[Medline]

This article has been cited by other articles:

				C. M. Ulrich, M. Neuhouser, A. Y. Liu, A. Boynton, J. F. Gregory III, B. Shane, S. J. James, M. C. Reed, and H. F. Nijhout Mathematical Modeling of Folate Metabolism: Predicted Effects of Genetic Polymorphisms on Mechanisms and Biomarkers Relevant to Carcinogenesis Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1822 - 1831. [Abstract] [Full Text] [PDF]

				S. Boccia, R. Hung, G. Ricciardi, F. Gianfagna, M. P. A. Ebert, J.-Y. Fang, C.-M. Gao, T. Gotze, F. Graziano, M. Lacasana-Navarro, et al. Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review Am. J. Epidemiol., March 1, 2008; 167(5): 505 - 516. [Abstract] [Full Text] [PDF]

				A. Y. Jung, E. M. Poole, J. Bigler, J. Whitton, J. D. Potter, and C. M. Ulrich DNA Methyltransferase and Alcohol Dehydrogenase: Gene-Nutrient Interactions in Relation to Risk of Colorectal Polyps Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 330 - 338. [Abstract] [Full Text] [PDF]

				M. van den Donk, L. Pellis, J. W. Crott, M. van Engeland, P. Friederich, F. M. Nagengast, J. D. van Bergeijk, S. Y. de Boer, J. B. Mason, F. J. Kok, et al. Folic Acid and Vitamin B-12 Supplementation Does Not Favorably Influence Uracil Incorporation and Promoter Methylation in Rectal Mucosa DNA of Subjects with Previous Colorectal Adenomas J. Nutr., September 1, 2007; 137(9): 2114 - 2120. [Abstract] [Full Text] [PDF]

				K. Curtin, M. L. Slattery, C. M. Ulrich, J. Bigler, T. R. Levin, R. K. Wolff, H. Albertsen, J. D. Potter, and W. S. Samowitz Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet Carcinogenesis, August 1, 2007; 28(8): 1672 - 1679. [Abstract] [Full Text] [PDF]

				R. J. Hung, M. Hashibe, J. McKay, V. Gaborieau, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, I. Mates, et al. Folate-related genes and the risk of tobacco-related cancers in Central Europe Carcinogenesis, June 1, 2007; 28(6): 1334 - 1340. [Abstract] [Full Text] [PDF]

				R. A. Hubner, S. Lubbe, I. Chandler, and R. S. Houlston MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer Hum. Mol. Genet., May 1, 2007; 16(9): 1072 - 1077. [Abstract] [Full Text] [PDF]

				T. Forges, P. Monnier-Barbarino, J.M. Alberto, R.M. Gueant-Rodriguez, J.L. Daval, and J.L. Gueant Impact of folate and homocysteine metabolism on human reproductive health Hum. Reprod. Update, May 1, 2007; 13(3): 225 - 238. [Abstract] [Full Text] [PDF]

				V. S. Dhillon, M. Shahid, and S. A. Husain Associations of MTHFR DNMT3b 4977 bp deletion in mtDNA and GSTM1 deletion, and aberrant CpG island hypermethylation of GSTM1 in non-obstructive infertility in Indian men Mol. Hum. Reprod., April 1, 2007; 13(4): 213 - 222. [Abstract] [Full Text] [PDF]

				I.M.W. Ebisch, C.M.G. Thomas, W.H.M. Peters, D.D.M. Braat, and R.P.M. Steegers-Theunissen The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility Hum. Reprod. Update, March 1, 2007; 13(2): 163 - 174. [Abstract] [Full Text] [PDF]

				J. Han, G. A. Colditz, and D. J. Hunter Polymorphisms in the MTHFR and VDR genes and skin cancer risk Carcinogenesis, February 1, 2007; 28(2): 390 - 397. [Abstract] [Full Text] [PDF]

				A.T. Dobson, R.M. Davis, M.P. Rosen, S. Shen, P.F. Rinaudo, J. Chan, and M.I. Cedars Methylenetetrahydrofolate reductase C677T and A1298C variants do not affect ongoing pregnancy rates following IVF Hum. Reprod., February 1, 2007; 22(2): 450 - 456. [Abstract] [Full Text] [PDF]

				M. C. Reed, H. F. Nijhout, M. L. Neuhouser, J. F. Gregory III, B. Shane, S. J. James, A. Boynton, and C. M. Ulrich A Mathematical Model Gives Insights into Nutritional and Genetic Aspects of Folate-Mediated One-Carbon Metabolism J. Nutr., October 1, 2006; 136(10): 2653 - 2661. [Abstract] [Full Text] [PDF]

				S. Niclot, Q. Pruvot, C. Besson, D. Savoy, E. Macintyre, G. Salles, N. Brousse, B. Varet, P. Landais, P. Taupin, et al. Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas Blood, July 1, 2006; 108(1): 278 - 285. [Abstract] [Full Text] [PDF]

				H. J. Powers Interaction among Folate, Riboflavin, Genotype, and Cancer, with Reference to Colorectal and Cervical Cancer J. Nutr., December 1, 2005; 135(12): 2960S - 2966S. [Abstract] [Full Text] [PDF]

				C. M. Ulrich, K. Curtin, W. Samowitz, J. Bigler, J. D. Potter, B. Caan, and M. L. Slattery MTHFR Variants Reduce the Risk of G:C->A:T Transition Mutations within the p53 Tumor Suppressor Gene in Colon Tumors J. Nutr., October 1, 2005; 135(10): 2462 - 2467. [Abstract] [Full Text] [PDF]

				A. M. Eaton, R. Sandler, J. M. Carethers, R. C. Millikan, J. Galanko, and T. O. Keku 5,10-Methylenetetrahydrofolate Reductase 677 and 1298 Polymorphisms, Folate Intake, and Microsatellite Instability in Colon Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2023 - 2029. [Abstract] [Full Text] [PDF]

				M. A. Orjuela, L. Titievsky, X. Liu, M. Ramirez-Ortiz, V. Ponce-Castaneda, E. Lecona, E. Molina, K. Beaverson, D. H. Abramson, and N. E. Mueller Fruit and Vegetable Intake during Pregnancy and Risk for Development of Sporadic Retinoblastoma Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1433 - 1440. [Abstract] [Full Text] [PDF]

				D. Li, M. Ahmed, Y. Li, L. Jiao, T.-H. Chou, R. A. Wolff, R. Lenzi, D. B. Evans, M. L. Bondy, P. W. Pisters, et al. 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1470 - 1476. [Abstract] [Full Text] [PDF]

				M Pufulete, R Al-Ghnaniem, A Khushal, P Appleby, N Harris, S Gout, P W Emery, and T A B Sanders Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma Gut, May 1, 2005; 54(5): 648 - 653. [Abstract] [Full Text] [PDF]

				S. Friso, D. Girelli, E. Trabetti, O. Olivieri, P. Guarini, P. F. Pignatti, R. Corrocher, and S.-W. Choi The MTHFR 1298A>C Polymorphism and Genomic DNA Methylation in Human Lymphocytes Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 938 - 943. [Abstract] [Full Text] [PDF]

				E. P. Quinlivan, S. R. Davis, K. P. Shelnutt, G. N. Henderson, H. Ghandour, B. Shane, J. Selhub, L. B. Bailey, P. W. Stacpoole, and J. F. Gregory III Methylenetetrahydrofolate Reductase 677C->T Polymorphism and Folate Status Affect One-Carbon Incorporation into Human DNA Deoxynucleosides J. Nutr., March 1, 2005; 135(3): 389 - 396. [Abstract] [Full Text] [PDF]

				J. Chen, M. D. Gammon, W. Chan, C. Palomeque, J. G. Wetmur, G. C. Kabat, S. L. Teitelbaum, J. A. Britton, M. B. Terry, A. I. Neugut, et al. One-Carbon Metabolism, MTHFR Polymorphisms, and Risk of Breast Cancer Cancer Res., February 15, 2005; 65(4): 1606 - 1614. [Abstract] [Full Text] [PDF]

				S. Narayanan, J. McConnell, J. Little, L. Sharp, C. J. Piyathilake, H. Powers, G. Basten, and S. J. Duthie Associations between Two Common Variants C677T and A1298C in the Methylenetetrahydrofolate Reductase Gene and Measures of Folate Metabolism and DNA Stability (Strand Breaks, Misincorporated Uracil, and DNA Methylation Status) in Human Lymphocytes In vivo Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1436 - 1443. [Abstract] [Full Text] [PDF]

				J. A. Milner Molecular Targets for Bioactive Food Components J. Nutr., September 1, 2004; 134(9): 2492S - 2498S. [Abstract] [Full Text] [PDF]

				M. S. Cicek, N. L. Nock, L. Li, D. V. Conti, G. Casey, and J. S. Witte Relationship between Methylenetetrahydrofolate Reductase C677T and A1298C Genotypes and Haplotypes and Prostate Cancer Risk and Aggressiveness Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1331 - 1336. [Abstract] [Full Text] [PDF]

				G. P. Basten, M. H. Hill, S. J. Duthie, and H. J. Powers Effect of Folic Acid Supplementation on the Folate Status of Buccal Mucosa and Lymphocytes Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1244 - 1249. [Abstract] [Full Text] [PDF]

				R Castro, I Rivera, P Ravasco, M E Camilo, C Jakobs, H J Blom, and I T de Almeida 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C->T and 1298A->C mutations are associated with DNA hypomethylation J. Med. Genet., June 1, 2004; 41(6): 454 - 458. [Full Text] [PDF]

				D. Gemmati, A. Ongaro, G. L. Scapoli, M. Della Porta, S. Tognazzo, M. L. Serino, E. Di Bona, F. Rodeghiero, G. Gilli, R. Reverberi, et al. Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin's Lymphoma in Adults Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 787 - 794. [Abstract] [Full Text] [PDF]

				R. De Bont and N. van Larebeke Endogenous DNA damage in humans: a review of quantitative data Mutagenesis, May 1, 2004; 19(3): 169 - 185. [Abstract] [Full Text] [PDF]

L. Sharp and J. Little Polymorphisms in Genes Involved in Folate Metabolism and Colorectal Neoplasia: A HuGE Review Am. J. Epidemiol., March 1, 2004; 159(5): 423 - 443. [Abstract] [Full Text] [PDF]